<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR1800014570</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2018-01-22</date_registration>
      <primary_sponsor>First Affiliated Hospital of Nanchang University </primary_sponsor>
      <public_title>The clinical study on the treatment of umbilical cord mesenchymal stem cells for refractory Graves' ophthalmopathy</public_title>
      <acronym />
      <scientific_title>The clinical study on the treatment  of umbilical cord mesenchymal stem cells for refractory Graves' ophthalmopathy</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2018-02-08</date_enrolment>
      <type_enrolment />
      <target_size>Case series:15;</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=24044</url>
      <study_type>Observational study</study_type>
      <study_design>Case series</study_design>
      <phase>New Treatment Measure Clinical Study</phase>
      <hc_freetext>Graves' ophthalmopathy</hc_freetext>
      <i_freetext>Case series:umbilical cord mesenchymal stem cells;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Xu Jixiong</firstname>
        <middlename />
        <lastname />
        <address>17 Yongwaizheng Street, Nanchang, Jiangxi, China</address>
        <city />
        <country1 />
        <zip>3330006</zip>
        <telephone>+86 13307086069</telephone>
        <email>xujixiong@163.com</email>
        <affiliation>First Affiliated Hospital of Nanchang University </affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Xu Jixiong</firstname>
        <middlename />
        <lastname />
        <address>17 Yongwaizheng Street, Nanchang, Jiangxi, China</address>
        <city />
        <country1 />
        <zip>330006</zip>
        <telephone>+86 13307086069</telephone>
        <email>xujixiong@163.com</email>
        <affiliation>First Affiliated Hospital of Nanchang University </affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. Aged from 18 to 75 years; 
2. Diagnosis of GO; 
3. Moderate-to-severe GO;
4. CAS≥3/7;
5. limited effect on glucocorticoid treatment;
6. Patients volunteered to participate in and sign the consent form.</inclusion_criteria>
      <agemin>18</agemin>
      <agemax>75</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. Need immediate orbital decompression;
2. No corneal perforation or ulcer;
3. Not administered to biological agents,immunosuppressive therapy;
4. those with severe heart, liver, renal insufficiency.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>CAS score;NOSPECS score;orbit MRI;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>IL-10;INF-γ;FT3;FT4;TSH;TRAb;TGF-β;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Jiangxi province science and technology plan key projects</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-07-14</approval_date>
        <contact_name>Liu Jichun</contact_name>
        <contact_address>17 Yongwaizheng Street, Nanchang, Jiangxi, China</contact_address>
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>